These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38537159)

  • 1. Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility.
    Potter AL; Xu NN; Senthil P; Srinivasan D; Lee H; Gazelle GS; Chelala L; Zheng W; Fintelmann FJ; Sequist LV; Donington J; Palmer JR; Yang CJ
    J Clin Oncol; 2024 Jun; 42(17):2026-2037. PubMed ID: 38537159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent race- and sex-based disparities in lung cancer screening eligibility.
    Potter AL; Senthil P; Srinivasan D; Raman V; Kumar A; Haridas C; Mathey-Andrews C; Zheng W; Jeffrey Yang CF
    J Thorac Cardiovasc Surg; 2024 Jul; 168(1):248-260.e2. PubMed ID: 37863179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.
    Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW
    JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
    Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
    JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in Eligibility.
    Pu CY; Lusk CM; Neslund-Dudas C; Gadgeel S; Soubani AO; Schwartz AG
    JAMA Oncol; 2022 Mar; 8(3):374-382. PubMed ID: 35024781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines.
    Pinheiro LC; Groner L; Soroka O; Prosper AE; Jack K; Tamimi RM; Safford M; Phillips E
    JAMA Netw Open; 2022 Sep; 5(9):e2229741. PubMed ID: 36053535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals.
    Gudina AT; Kamen C; Hardy SJ; Kehoe L; Culakova E; Cupertino AP
    Lung Cancer; 2024 May; 191():107539. PubMed ID: 38552545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.
    Aldrich MC; Mercaldo SF; Sandler KL; Blot WJ; Grogan EL; Blume JD
    JAMA Oncol; 2019 Sep; 5(9):1318-1324. PubMed ID: 31246249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
    Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
    J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking.
    Li CC; Matthews AK; Rywant MM; Hallgren E; Shah RC
    Cancer Causes Control; 2019 Mar; 30(3):235-240. PubMed ID: 30377905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening.
    Jia G; Wen W; Massion PP; Shu XO; Zheng W
    Carcinogenesis; 2021 Jun; 42(6):874-879. PubMed ID: 33640962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities of National Lung Cancer Screening Guidelines in the US Population.
    Han SS; Chow E; Ten Haaf K; Toumazis I; Cao P; Bastani M; Tammemagi M; Jeon J; Feuer EJ; Meza R; Plevritis SK
    J Natl Cancer Inst; 2020 Nov; 112(11):1136-1142. PubMed ID: 32040195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
    Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
    Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
    Toumazis I; de Nijs K; Cao P; Bastani M; Munshi V; Ten Haaf K; Jeon J; Gazelle GS; Feuer EJ; de Koning HJ; Meza R; Kong CY; Han SS; Plevritis SK
    JAMA Oncol; 2021 Dec; 7(12):1833-1842. PubMed ID: 34673885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
    Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
    CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US.
    Choi E; Ding VY; Luo SJ; Ten Haaf K; Wu JT; Aredo JV; Wilkens LR; Freedman ND; Backhus LM; Leung AN; Meza R; Lui NS; Haiman CA; Park SL; Le Marchand L; Neal JW; Cheng I; Wakelee HA; Tammemägi MC; Han SS
    JAMA Oncol; 2023 Dec; 9(12):1640-1648. PubMed ID: 37883107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the revised LDCT lung cancer screening guideline bridge the racial disparities gap: Results from the health and retirement study.
    Li CC; Manella J; Kefi SE; Matthews AK
    J Natl Med Assoc; 2024 Apr; 116(2 Pt 1):180-188. PubMed ID: 38245469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
    Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
    JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
    Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
    J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
    Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
    Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.